IL-6- and IL-10-induced p-STAT3 signatures in peripheral blood mononuclear cells may be used as diagnostic biomarkers to distinguish CRC patients from healthy individuals with a sensitivity and specificity of 91% and 88%, respectively. Here, STAT3 is linked to colorectal carcinoma.